NY A05860 | 2021-2022 | General Assembly
Status
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: Introduced on March 1 2021 - 25% progression, died in chamber
Action: 2022-06-01 - substituted by s3081b
Text: Latest bill text (Amended) [HTML]
Status: Introduced on March 1 2021 - 25% progression, died in chamber
Action: 2022-06-01 - substituted by s3081b
Text: Latest bill text (Amended) [HTML]
Summary
Prohibits selling a drug subject to a shortage for an unconscionably excessive price.
Title
Prohibits selling a drug subject to a shortage for an unconscionably excessive price.
Sponsors
| Asm. Karines Reyes [D] | Asm. Jaime Williams [D] | Asm. Steven Otis [D] | Asm. Judy Griffin [D] |
| Asm. Mary Walsh [R] |
Roll Calls
2022-06-01 - Assembly - Assembly Rules Committee: Favorable (Y: 28 N: 0 NV: 0 Abs: 3) [PASS]
2022-05-31 - Assembly - Assembly Codes Committee: Favorable refer to committee Rules (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2022-03-29 - Assembly - Assembly Consumer Affairs And Protection Committee: Favorable refer to committee Codes (Y: 12 N: 3 NV: 0 Abs: 1) [PASS]
2022-05-31 - Assembly - Assembly Codes Committee: Favorable refer to committee Rules (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2022-03-29 - Assembly - Assembly Consumer Affairs And Protection Committee: Favorable refer to committee Codes (Y: 12 N: 3 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2022-06-01 | Assembly | substituted by s3081b |
| 2022-06-01 | Assembly | rules report cal.528 |
| 2022-06-01 | Assembly | reported |
| 2022-05-31 | Assembly | reported referred to rules |
| 2022-05-13 | Assembly | print number 5860b |
| 2022-05-13 | Assembly | amend and recommit to codes |
| 2022-03-29 | Assembly | reported referred to codes |
| 2022-01-05 | Assembly | referred to consumer affairs and protection |
| 2021-12-29 | Assembly | print number 5860a |
| 2021-12-29 | Assembly | amend and recommit to consumer affairs and protection |
| 2021-03-01 | Assembly | referred to consumer affairs and protection |
Same As/Similar To
S03081 (Same As) 2022-12-23 - VETOED MEMO.162
